drugset / Trial / NCT03442972
Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral Lipids
Phase 2/3
Completed
21 enrolled
University Health Network, Toronto
Kensington Screening Clinic · collab
RandomizedParallel-groupSingle-blindBasic science
Summary
Some of the fat (triglyceride) from the food humans eat gets stored in the bowel. This triglyceride can then be released into the blood when another meal is consumed or in response to hormones. How the gut hormone glucagon-like peptide-2 (GLP-2) releases the triglyceride from the gut is not known. The research team in this study is interested in finding out how teduglutide (a degradation resistant form of GLP-2) releases stored triglyceride from the gut by studying samples from patients undergoing endoscopy and small bowel biopsy.
Timeline
- Start
- 2019-01-17
- Primary completion
- 2021-06-01
- Completion
- 2021-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Teduglutide | Peptide | 0.05 mg/kg | Subcutaneous |